Using a combination of reverse transcriptase polymerase chain reaction to detect specific mRNA and immunohistochemistry employing antibodies that recognize two different epitopes for each molecule, the local production of oxytocin (OT) and its cognate receptor was investigated in the male marmoset monkey (Callithrix jacchus). There was synthesis of both OT and the oxytocin receptor (OTR) within the testis, and both were markedly expressed within the Leydig cells. A weak staining for both OT and its associated neurophysin could also be detected in Sertoli cells in some animals. Expression of OT or neurophysin does not appear to be significant in the epididymis, though there appears to be synthesis of the receptor in some peritubular muscle cells of the epididymis and in the vas deferens. Within the prostate, there appears to be no production of OT or neurophysin, though there appears to be weak expression of the OTR in the basal layers of the secretory epithelium. Similarly in the bulbourethral gland, only OTR immunoreactivity could be detected. Receptors appear to be present in the myoid cells encompassing the glandular lobules and are presumably able to respond to systemic OT. An analysis of juvenile marmosets indicates that the testicular OT system appears to become established during puberty. Thus, in this New World monkey the testis is able to support a local OT-based paracrine-type system, though the prostate and bulbourethral gland are probably only able to respond to exogenous OT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1095/biolreprod56.2.416 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanosensation of the heart and gut elicits hypometabolism and vigilance in mice.
Nat Metab
January 2025
Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, GA, USA.
Interoception broadly refers to awareness of one's internal milieu. Although the importance of the body-to-brain communication that underlies interoception is implicit, the vagal afferent signalling and corresponding brain circuits that shape perception of the viscera are not entirely clear. Here, we use mice to parse neural circuits subserving interoception of the heart and gut.
View Article and Find Full Text PDFNegative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.
CNS Drugs
January 2025
New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA.
Article Synopsis
- The negative symptoms of schizophrenia, like lack of emotion and motivation, are hard to treat and significantly impact daily functioning.
- This review highlights current research on treatment options for these symptoms, categorizing them into different types and evaluating various assessment scales.
- Although no treatments are conclusively proven as the best for these symptoms, some off-label and investigational medications show promise, including cariprazine and memantine, and further research is needed to explore new therapeutic possibilities.
Gestational stress disrupts dopamine and oxytocin signaling in the postpartum reward system of rats: implications for mood, motivation and mothering.
Sci Rep
January 2025
Neuroscience Graduate Program, The Ohio State University, Columbus, OH, 43210, USA.
Postpartum depression (PPD) affects up to 20% of new mothers and has adverse consequences for the well-being of both mother and child. Exposure to stress during pregnancy as well as dysregulation in the mesolimbic dopamine (DA) reward system and its upstream modulator oxytocin (OT) have been independently linked to PPD. However, no studies have directly examined DA or OT signaling in the postpartum brain after gestational stress.
View Article and Find Full Text PDFNeurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.
Prog Neuropsychopharmacol Biol Psychiatry
January 2025
Department of Psychiatry, University Medical Center Groningen, Groningen, the Netherlands.
Psilocybin represents a novel therapeutic approach for individuals with major depressive disorder (MDD) who do not respond to conventional antidepressant treatment. Investigating the influence of psilocybin on the pathophysiological processes involved in MDD could enhance our neurobiological understanding of the presumed antidepressant action mechanism. This systematic review aims to summarize the results of human studies investigating changes in blood-based biomarkers of MDD to guide future research on potentially relevant analytes that could be monitored in clinical trials.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!